Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,241,990 papers from all fields of science
Search
Sign In
Create Free Account
Midrin
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Broader (8)
Acetaminophen
Acetaminophen / dichloralphenazone / isometheptene
Antipyrine
Chloral Hydrate
Expand
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Migraine, Midrin, and Imitrex
S. Landy
,
Mary S. Richardson
,
S. O’Quinn
Headache
2002
Corpus ID: 43662367
1997
1997
Autonomic Dysreflexia Syndrome Due to Midrin?: A Warning from the Past
D. Palmer
1997
Corpus ID: 75311237
1996
1996
Computerized drug interaction programs: how reliable?
K. E. Kraft
,
F. Dore
Journal of the American Medical Association (JAMA…
1996
Corpus ID: 5525781
ABSTRACT To the Editor. —How often do we prescribe two or more adversely interacting drugs to the same patient? Maybe more often…
Expand
1995
1995
Toward a Standard Drug Formulary for the Treatment of Headache
J. Klapper
Headache
1995
Corpus ID: 21877206
The recent publication of drug formularies by third‐party payers has serious implications for the practice of medicine. These…
Expand
1985
1985
Autonomic dysreflexia due to medication: misadventure in the use of an isometheptene combination to treat migraine.
M. A. Wineinger
,
J. Basford
Archives of Physical Medicine and Rehabilitation
1985
Corpus ID: 7635399
Autonomic dysreflexia, a syndrome sometimes occurring in spinal cord injured (SCI) individuals, may be life-threatening. It…
Expand
1966
1966
[A clinical study for the effect of Midrin M on the visual acuity and refraction in myopic children. VI].
R. Yamaji
,
M. Yoshihara
,
I. Furuta
,
A. Sakiyama
,
K. Ishikawa
Nihon ganka kiyo
1966
Corpus ID: 28482400
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required